Código QR

Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses

Abstract Filgotinib is an oral preferential Janus kinase 1 inhibitor that demonstrated significant reductions in radiographic progression, with an acceptable tolerability and safety profile, vs placebo in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX-IR; FIN...

Descrición completa

Gardado en:
Principais autores: Yoshiya Tanaka, Tsutomu Takeuchi, Tatsuya Atsumi, Bernard G. Combe, Daniel Aletaha, Toshihiko Kaise, Vijay Rajendran
Formato: Artigo
Idioma:Inglês
Publicado: Adis, Springer Healthcare 2023-09-01
Series:Rheumatology and Therapy
Assuntos:
Filgotinib
Poor prognostic factors
Adalimumab
Methotrexate
Rheumatoid arthritis
Acceso en liña:https://doi.org/10.1007/s40744-023-00590-w
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares